Drug To Prevent Premature Birth Divides Doctors, Insurers And FDA Experts
An expert panel convened by the FDA says the drug Makena should be withdrawn from the market because a review of its effectiveness shows it doesn't work. But OB-GYNS who prescribe the drug disagree.
Read more on NPR
Blog Beauty 24/7
Research News
January 24, 2020 at 11:23PM
Không có nhận xét nào:
Đăng nhận xét